Zuellig Pharma has relocated its clinical depot to Misato, Japan. This move enhances its capability to deliver global quality standards with local operational agility, strengthening its clinical supply chain across the Asia Pacific region. The new facility aims to support both domestic and international clinical research needs.
The establishment of a new, advanced clinical depot in Misato, Japan, signifies Zuellig Pharma's commitment to expanding its clinical trial support services in a key Asian market. This investment in infrastructure improves their ability to handle complex logistics for clinical research, potentially attracting more global pharmaceutical companies to conduct trials in Japan and the wider APAC region, thereby increasing their market share in clinical supply chain services.
Zuellig Pharma relocated its clinical depot to Misato, Japan.
Enhances clinical supply capability and operational agility in Asia Pacific.
Supports global quality standards for clinical research.
Zuellig Pharma's new clinical depot in Misato, Japan, directly addresses the growing demand for advanced clinical logistics and sourcing excellence within the Japanese and broader Asia Pacific pharmaceutical research landscape.
Enhances clinical supply capability and operational agility in Asia Pacific.
Supports global quality standards for clinical research.
Sign in to save notes on signals.
Sign In